63.32
price down icon4.44%   -2.94
after-market アフターアワーズ: 63.25 -0.07 -0.11%
loading
前日終値:
$66.26
開ける:
$66.51
24時間の取引高:
1.94M
Relative Volume:
1.37
時価総額:
$6.19B
収益:
-
当期純損益:
$-153.72M
株価収益率:
-31.66
EPS:
-2
ネットキャッシュフロー:
$-103.81M
1週間 パフォーマンス:
-12.94%
1か月 パフォーマンス:
+9.34%
6か月 パフォーマンス:
+64.13%
1年 パフォーマンス:
+329.29%
1日の値動き範囲:
Value
$62.81
$67.86
1週間の範囲:
Value
$62.81
$73.60
52週間の値動き範囲:
Value
$11.39
$74.18

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
名前
Verona Pharma Plc Adr
Name
セクター
Healthcare (1153)
Name
電話
011-44-0-2032834200
Name
住所
3 MORE LONDON RIVERSIDE, LONDON
Name
職員
209
Name
Twitter
@VeronaPharma
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
VRNA's Discussions on Twitter

VRNA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VRNA
Verona Pharma Plc Adr
63.32 6.19B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.99 128.84B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.78 65.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.65 39.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.15 33.82B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
231.99 27.60B 3.81B -644.79M -669.77M -6.24

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-28 開始されました TD Cowen Buy
2025-04-21 開始されました Cantor Fitzgerald Overweight
2025-01-10 開始されました ROTH MKM Buy
2024-10-03 開始されました Wells Fargo Overweight
2023-05-22 再開されました Jefferies Buy
2022-09-19 再開されました Wedbush Outperform
2022-08-26 開始されました Piper Sandler Overweight
2021-09-13 開始されました H.C. Wainwright Buy
2020-08-25 開始されました Jefferies Buy
2020-08-10 開始されました Canaccord Genuity Buy
2019-04-18 開始されました BTIG Research Buy
すべてを表示

Verona Pharma Plc Adr (VRNA) 最新ニュース

pulisher
May 08, 2025

Market Update: Verona Pharma Plc ADR (VRNA) Sees Negative Movement, Closing at 69.14 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA): An Enticing Stock To Watch - Stocksregister

May 08, 2025
pulisher
May 06, 2025

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025 - GlobeNewswire Inc.

May 06, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Verona Pharma director Vikas Sinha sells $178,416 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 - Investing.com

May 01, 2025
pulisher
May 01, 2025

Verona Pharma Plc ADR (VRNA)’s Market Momentum: Closing Strong at 72.07, Down -1.56 - DWinneX

May 01, 2025
pulisher
Apr 30, 2025

What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Verona Pharma Plc ADR [VRNA] Stock trading around $73.21 per share: What’s Next? - dbtnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

VRNA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Watch this stock’s price performance: Verona Pharma Plc ADR (NASDAQ:VRNA) - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Verona Pharma ADR earnings beat by $0.05, revenue topped estimates - Investing.com UK

Apr 29, 2025
pulisher
Apr 28, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Could Soar To Much Higher Prices In Coming Months - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 28, 2025

TD Cowen starts Verona Pharma stock at Buy, sets $100 target - Investing.com

Apr 28, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Verona Pharma Plc ADR (VRNA) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Is Astrazeneca plc ADR (AZN) positioned for future growth? - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Plc ADR [VRNA] Records 50-Day SMA of $62.73 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Tencent Music Entertainment Group ADR [TME] Officer makes an insider purchase of 1,036,363 shares worth 14.87 million. – Knox Daily - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

TAL Education Group ADR [TAL] Officer makes an insider purchase of 24,041 shares worth 0.28 million. - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Ratios Uncovered: Breaking Down Verona Pharma Plc ADR (VRNA)’s Trailing Twelve Months Metrics - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Verona Pharma Plc ADR (VRNA) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

What is the investor’s view on Marriott Vacations Worldwide Corp (VAC)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Was Phathom Pharmaceuticals Inc (PHAT)’s session last reading good? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Zentalis Pharmaceuticals Inc (ZNTL) deserves deeper analysis - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Health Report: Alamos Gold Inc (AGI)’s Ratios Tell a Tale - DWinneX

Apr 24, 2025
pulisher
Apr 21, 2025

Cantor Fitzgerald sets $80 target on Verona Pharma stock By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 17, 2025

Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit undervalued - uspostnews.com

Apr 17, 2025
pulisher
Apr 07, 2025

Verona Pharma Plc ADR [VRNA] Rickard Kathleen A. sells 79,264 Shares for $0.66 million - knoxdaily.com

Apr 07, 2025
pulisher
Apr 03, 2025

Verona Pharma Plc ADR [VRNA] Chief Medical Officer makes an insider purchase of 79,264 shares worth 0.66 million. - knoxdaily.com

Apr 03, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms - Investing.com

Mar 28, 2025
pulisher
Mar 25, 2025

The growth track for Cracker Barrel Old Country Store Inc (CBRL) has changed recently - SETE News

Mar 25, 2025
pulisher
Mar 18, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Up 298.80% This Year: What Is Going To Happen Next - Stocks Register

Mar 18, 2025
pulisher
Mar 14, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 10, 2025

Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

McEwen Mining Inc (MUX) Becoming More Attractive for Investors - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Morgan Stanley Upgrades Solaredge Technologies Inc (SEDG) to an Equal-weight from an Underweight - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Verona Pharma at Leerink Global Healthcare: Eutuvera’s Promising Launch By Investing.com - Investing.com UK

Mar 10, 2025
pulisher
Feb 28, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK

Feb 27, 2025
pulisher
Feb 21, 2025

A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily

Feb 21, 2025
pulisher
Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 - Investing.com India

Feb 12, 2025
pulisher
Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa

Feb 12, 2025

Verona Pharma Plc Adr (VRNA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):